J Melle

1.1k total citations
24 papers, 915 citations indexed

About

J Melle is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Melle has authored 24 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Genetics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Melle's work include Acute Myeloid Leukemia Research (10 papers), Platelet Disorders and Treatments (6 papers) and Blood properties and coagulation (4 papers). J Melle is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Platelet Disorders and Treatments (6 papers) and Blood properties and coagulation (4 papers). J Melle collaborates with scholars based in France. J Melle's co-authors include Michaëla Fontenay, Didier Bouscary, François Dreyfus, Françoise Picard, Catherine Vidal, Martine Guesnu, Sylvie Gisselbrecht, Martine Jandrot‐Perrus, Blandine Geny and F. Dreyfus and has published in prestigious journals such as Blood, Biochemical Journal and British Journal of Haematology.

In The Last Decade

J Melle

24 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Melle France 15 624 370 222 122 87 24 915
Philippe Rameau France 19 767 1.2× 406 1.1× 391 1.8× 183 1.5× 134 1.5× 36 1.2k
Nikla Emambokus United Kingdom 7 286 0.5× 321 0.9× 107 0.5× 151 1.2× 101 1.2× 7 737
NS Wolf United States 9 483 0.8× 274 0.7× 195 0.9× 165 1.4× 72 0.8× 13 741
Nancy L. Lin United States 13 1.0k 1.6× 348 0.9× 361 1.6× 283 2.3× 103 1.2× 17 1.4k
JE Brandt United States 11 691 1.1× 198 0.5× 234 1.1× 313 2.6× 67 0.8× 16 889
Nancy E. Kirschbaum United States 9 249 0.4× 310 0.8× 66 0.3× 94 0.8× 64 0.7× 13 635
Anne‐Sophie Ribba France 20 867 1.4× 138 0.4× 148 0.7× 385 3.2× 113 1.3× 52 1.2k
Gaylord J. Knutson United States 7 891 1.4× 373 1.0× 329 1.5× 188 1.5× 20 0.2× 8 1.2k
Pamela Daher United States 10 331 0.5× 299 0.8× 163 0.7× 158 1.3× 90 1.0× 15 727
T Papayannopoulou United States 18 641 1.0× 660 1.8× 403 1.8× 239 2.0× 82 0.9× 54 1.4k

Countries citing papers authored by J Melle

Since Specialization
Citations

This map shows the geographic impact of J Melle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Melle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Melle more than expected).

Fields of papers citing papers by J Melle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Melle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Melle. The network helps show where J Melle may publish in the future.

Co-authorship network of co-authors of J Melle

This figure shows the co-authorship network connecting the top 25 collaborators of J Melle. A scholar is included among the top collaborators of J Melle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Melle. J Melle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vidal, Catherine, Blandine Geny, J Melle, Martine Jandrot‐Perrus, & Michaëla Fontenay. (2002). Cdc42/Rac1-dependent activation of the p21-activated kinase (PAK) regulates human platelet lamellipodia spreading: implication of the cortical-actin binding protein cortactin. Blood. 100(13). 4462–4469. 134 indexed citations
2.
Claessens, Yann-Érick, Didier Bouscary, Jean‐Michel Dupont, et al.. (2002). In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis. Blood. 99(5). 1594–1601. 113 indexed citations
3.
Duprez, V, et al.. (2001). Thrombopoietin stimulates cortactin translocation to the cytoskeleton independently of tyrosine phosphorylation. Biochemical Journal. 356(3). 875–875. 4 indexed citations
4.
Vidal, Catherine, Christian Spaulding, Françoise Picard, et al.. (2001). Flow Cytometry Detection of Platelet Procoagulant Activity and Microparticles in Patients with Unstable Angina Treated by Percutaneous Coronary Angioplasty and Stent Implantation. Thrombosis and Haemostasis. 86(9). 784–790. 43 indexed citations
5.
Vidal, Catherine, Christian Spaulding, Fabienne Picard, et al.. (2001). Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation.. PubMed. 86(3). 784–90. 51 indexed citations
6.
Duprez, V, et al.. (2001). Thrombopoietin stimulates cortactin translocation to the cytoskeleton independently of tyrosine phosphorylation. Biochemical Journal. 356(3). 875–881. 14 indexed citations
7.
Fontenay, Michaëla, Didier Bouscary, Martine Guesnu, et al.. (1999). Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction. British Journal of Haematology. 106(2). 464–473. 51 indexed citations
8.
Fontenay, Michaëla, et al.. (1998). Thrombopoietin activates human platelets and induces tyrosine phosphorylation of p80/85 cortactin.. PubMed. 79(1). 195–201. 17 indexed citations
9.
Fontenay, Michaëla, Didier Bouscary, J Melle, et al.. (1997). Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias. PubMed. 39(1). 5–10. 21 indexed citations
10.
Bouscary, Didier, John De Vos, Martine Guesnu, et al.. (1997). Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia. 11(6). 839–845. 140 indexed citations
11.
Bouscary, Didier, John De Vos, Martine Guesnu, et al.. (1997). 101 Apoptosis and fas antigen (CD95) expression in myclodysplasia. Leukemia Research. 21(1). S26–S26. 1 indexed citations
12.
Bouscary, Didier, et al.. (1995). c-mplExpression in Hematologic Disorders. Leukemia & lymphoma. 17(1-2). 19–26. 14 indexed citations
13.
Bouscary, Didier, Claude Preudhomme, Vincent Ribrag, et al.. (1995). Prognostic value of c-mpl expression in myelodysplastic syndromes.. PubMed. 9(5). 783–8. 31 indexed citations
14.
Dreyfus, François, et al.. (1995). Expression of the Evi-1 gene in myelodysplastic syndromes.. PubMed. 9(1). 203–5. 26 indexed citations
15.
Dreyfus, F., Didier Bouscary, J Melle, et al.. (1994). Expression of the EVI-1 gene in myelodysplastic syndromes. Leukemia Research. 18. 50–50. 18 indexed citations
16.
Dreyfus, François, et al.. (1993). Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high‐dose chemotherapy. British Journal of Haematology. 85(2). 411–412. 20 indexed citations
17.
Vigon, Isabelle, F. Dreyfus, J Melle, et al.. (1993). Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood. 82(3). 877–883. 79 indexed citations
18.
Rouer, Évelyne, F. Dreyfus, J Melle, Vincent Ribrag, & Richard Bénarous. (1993). Selective increase of alternatively spliced Lck transcripts from the proximal promotor in hematopoietic malignancies.. PubMed. 7(2). 246–50. 5 indexed citations
19.
Fichelson, Serge, F. Dreyfus, Roland Berger, et al.. (1992). Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region.. PubMed. 6(2). 93–9. 72 indexed citations
20.
Zindy, Frédérique, et al.. (1992). Cyclin a expression in human hematological malignancies: A new marker of cell proliferation. Biology of the Cell. 76(2). 268–268. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026